In HNSCC patients and the MOC2 syngeneic mouse model that is considered immunologically “cold”, K17 expression was inversely correlated with CD8+ cell infiltration, patients’ response to immune check point therapy, and in vivo tumor growth in mice [15]. Here, KRT17 is linked to head and neck squamous cell carcinoma.